Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
INR recovers momentum as local equities rebound; recent oil and dollar spike fades amid signs of easing geopolitical tensions
The Indian rupee recovered momentum to settle higher by around 28 paise at Rs 95.31 per dollar on Tuesday, supported by retreating international oil prices and small pullback in dollar overseas. Meanwhile, local equities also rebounded from two-month lows as a halt in hostilities between Israel and Iran boosted hopes that peace negotiations could move forward. Geopolitical tensions eased somewhat, the dollar weakened and Brent crude futures fell below $93 a barrel as Israel and Iran agreed to halt attacks against each other following a series of mutual attacks from Sunday night, which marked the most serious escalation since the ceasefire in April. The BSE Sensex settled 394.50 points (0.54%) higher at 73,918.76, while the NSE Nifty 50 advanced 119.10 points (0.52%) to close at 23,242.10.

Should You Own More Gold? Experts Weigh In After ETF Restrictions Across Mutual Funds
Both advisors argued that the discussion should not be limited to gold. Instead, it should prompt investors to think more broadly about diversification.
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.

NLC India shares in focus as government's Offer For Sale opens for non-retail investors
Among the public shareholders, mutual funds of India had a 9.49% stake in NLC India, led mainly by Nippon Life India AMC (5.65%) and Kotak Mahindra MF (2.6%). The stock is up over 30% so far in 2026.

Grasim announces ₹3,094-cr investment for lyocell capacity expansion in Karnataka plant
The expansion will add 110,000 TPA capacity at Harihar; total cellulosic staple fibre capacity slated to exceed one million tonnes annually by 2030. Grasim Industries, a Aditya Birla Group company, shares closed at ₹3,060.30 on the NSE on June 8, down 0.89%, or ₹27.40.
Sebi reviews broker net-worth norms, IPO price discovery framework
Market regulator is examining broker capital requirements, IPO auction mechanisms, mutual fund liquidity rules and corporate bond market reforms to improve efficiency

Tata Mutual Fund Curbs Large Inflows Into Gold ETFs Amid Record Surge in Demand
Tata Mutual Fund offers investors two routes to gain exposure to gold ETFs.

Global Capital Is Chasing AI Giants, But India Remains a Stock Picker's Market, Says Hiren Ved
The veteran fund manager noted that while the Nifty has largely moved sideways over the past two years, several stocks have generated substantial returns during the same period.

Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a row - Mint
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a rowMint